Gemtuzumab [gemtuzumab]

topical
16
Terms

gemtuzumab ozogamicin
gemtuzumab-ozogamicin
Mylotarg

 

CMA 676
CMA-676
Gemtuzumab Ozogamicin
Gemtuzumab-Ozogamicin
Mylotarg

Persistent link   https://www.medvik.cz/link/D000079982
Definition

Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.

DUI
D000079982 MeSH Browser
CUI
M0398183
History note
2020 (2000)
Public note
2020; GEMTUZUMAB was indexed under AMINOGLYCOSIDES and ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019; and under ANTIBODIES, MONOCLONAL 2000-2011

Allowable subheadings

AD
administration & dosage 5
AE
adverse effects 2
AN
analysis
BL
blood
CF
cerebrospinal fluid
CH
chemistry
CL
classification
DE
drug effects
EC
economics 1
GE
genetics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics 1
PD
pharmacology 6
PO
poisoning
RE
radiation effects
TU
therapeutic use 9
TO
toxicity
UL
ultrastructure
UR
urine

D Chemicals and Drugs
D09 Carbohydrates 724
D09.408 Glycosides 235
D09.408.051 Aminoglycosides 126
D09.408.051.247 Calicheamicins 1
D09.408.051.247.500 Gemtuzumab 16
D09.408.051.247.750 Inotuzumab Ozogamicin 12
D12 Amino Acids, Peptides, and Proteins 16
D12.776 Proteins 2 581
D12.776.124 Blood Proteins 909
D12.776.124.486 Immunoproteins 14
D12.776.124.486.485 Immunoglobulins 1 492
D12.776.124.486.485.114 Antibodies 1 815
D12.776.124.486.485.114.224 Antibodies, Monoclonal 4 659
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized 2 854
D12.776.124.486.485.114.224.060.125 Abciximab 14
D12.776.124.486.485.114.224.060.250 Adalimumab 349
D12.776.124.486.485.114.224.060.313 Alemtuzumab 125
D12.776.124.486.485.114.224.060.344 Basiliximab 2
D12.776.124.486.485.114.224.060.375 Bevacizumab 452
D12.776.124.486.485.114.224.060.438 Brentuximab Vedotin 42
D12.776.124.486.485.114.224.060.500 Certolizumab Pegol 47
D12.776.124.486.485.114.224.060.750 Cetuximab 186
D12.776.124.486.485.114.224.060.766 Daclizumab 6
D12.776.124.486.485.114.224.060.782 Denosumab 153
D12.776.124.486.485.114.224.060.790 Gemtuzumab 16
D12.776.124.486.485.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.486.485.114.224.060.798 Ipilimumab 263
D12.776.124.486.485.114.224.060.813 Natalizumab 157
D12.776.124.486.485.114.224.060.829 Nivolumab 449
D12.776.124.486.485.114.224.060.844 Omalizumab 112
D12.776.124.486.485.114.224.060.860 Palivizumab 12
D12.776.124.486.485.114.224.060.864 Panitumumab 58
D12.776.124.486.485.114.224.060.866 Ramucirumab 1
D12.776.124.486.485.114.224.060.868 Ranibizumab 61
D12.776.124.486.485.114.224.060.875 Trastuzumab 274
D12.776.124.486.485.114.224.060.937 Ustekinumab 121
D12.776.124.790 Serum Globulins 61
D12.776.124.790.651 Immunoglobulins 1 492
D12.776.124.790.651.114 Antibodies 1 815
D12.776.124.790.651.114.224 Antibodies, Monoclonal 4 659
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized 2 854
D12.776.124.790.651.114.224.060.125 Abciximab 14
D12.776.124.790.651.114.224.060.250 Adalimumab 349
D12.776.124.790.651.114.224.060.375 Alemtuzumab 125
D12.776.124.790.651.114.224.060.407 Basiliximab 2
D12.776.124.790.651.114.224.060.438 Bevacizumab 452
D12.776.124.790.651.114.224.060.469 Brentuximab Vedotin 42
D12.776.124.790.651.114.224.060.500 Certolizumab Pegol 47
D12.776.124.790.651.114.224.060.750 Cetuximab 186
D12.776.124.790.651.114.224.060.766 Daclizumab 6
D12.776.124.790.651.114.224.060.782 Denosumab 153
D12.776.124.790.651.114.224.060.790 Gemtuzumab 16
D12.776.124.790.651.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.790.651.114.224.060.798 Ipilimumab 263
D12.776.124.790.651.114.224.060.813 Natalizumab 157
D12.776.124.790.651.114.224.060.829 Nivolumab 449
D12.776.124.790.651.114.224.060.844 Omalizumab 112
D12.776.124.790.651.114.224.060.860 Palivizumab 12
D12.776.124.790.651.114.224.060.864 Panitumumab 58
D12.776.124.790.651.114.224.060.866 Ramucirumab 1
D12.776.124.790.651.114.224.060.868 Ranibizumab 61
D12.776.124.790.651.114.224.060.875 Trastuzumab 274
D12.776.124.790.651.114.224.060.937 Ustekinumab 121
D12.776.377 Globulins 68
D12.776.377.715 Serum Globulins 61
D12.776.377.715.548 Immunoglobulins 1 492
D12.776.377.715.548.114 Antibodies 1 815
D12.776.377.715.548.114.224 Antibodies, Monoclonal 4 659
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized 2 854
D12.776.377.715.548.114.224.200.125 Abciximab 14
D12.776.377.715.548.114.224.200.250 Adalimumab 349
D12.776.377.715.548.114.224.200.375 Alemtuzumab 125
D12.776.377.715.548.114.224.200.407 Basiliximab 2
D12.776.377.715.548.114.224.200.438 Bevacizumab 452
D12.776.377.715.548.114.224.200.469 Brentuximab Vedotin 42
D12.776.377.715.548.114.224.200.500 Certolizumab Pegol 47
D12.776.377.715.548.114.224.200.750 Cetuximab 186
D12.776.377.715.548.114.224.200.766 Daclizumab 6
D12.776.377.715.548.114.224.200.782 Denosumab 153
D12.776.377.715.548.114.224.200.790 Gemtuzumab 16
D12.776.377.715.548.114.224.200.794 Inotuzumab Ozogamicin 12
D12.776.377.715.548.114.224.200.798 Ipilimumab 263
D12.776.377.715.548.114.224.200.813 Natalizumab 157
D12.776.377.715.548.114.224.200.829 Nivolumab 449
D12.776.377.715.548.114.224.200.844 Omalizumab 112
D12.776.377.715.548.114.224.200.860 Palivizumab 12
D12.776.377.715.548.114.224.200.864 Panitumumab 58
D12.776.377.715.548.114.224.200.866 Ramucirumab 1
D12.776.377.715.548.114.224.200.868 Ranibizumab 61
D12.776.377.715.548.114.224.200.875 Trastuzumab 274
D12.776.377.715.548.114.224.200.937 Ustekinumab 121

Back Add